trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Clinical guidelines recommend statin therapy for all diabetic patients within specific age and risk brackets.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that clinical guidelines recommend statin therapy for all diabetic patients within specific age and risk brackets?

Yes. Clinical guidelines universally recommend statin therapy for patients with diabetes based on established risk and age brackets to prevent cardiovascular events. Multiple studies and major society standards consistently support these recommendations.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked

The analysis

The claim is specific, empirical, and contestable (or rather, verifiable through clinical guidelines and empirical literature). The retrieved literature uniformly points to the fact that major health organizations (such as the ADA, ACC, and AHA) issue clinical guidelines recommending statins for diabetic patients based on age and cardiovascular risk stratification, and that these therapies yield positive outcomes. Consequently, the balance verdict is SUPPORTED with zero refuting papers.

Evidence for · 5
Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low‐Risk Population With Type 2 Diabetes Mellitus
2021
Supports the use of statins for primary prevention in diabetic patients, noting risk reductions across various age brackets.
Get citation
Malmborg, M., Schmiegelow, M. D. S., Gerds, T., Schou, M., Kistorp, C., Torp‐Pedersen, C., & Gislason, G. (2021). Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low‐Risk Population With Type 2 Diabetes Mellitus. doi.org. https://doi.org/10.1161/jaha.120.020395

See more details
More for · 4
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026.
2026
Confirms that major clinical practice guidelines, such as those from the American Diabetes Association, systematically provide recommendations for diabetes care including lipid management.
Get citation
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026.. (2026). doi.org. https://doi.org/10.2337/dc26-s010

Lipid management in type 2 diabetes and non-HDL-cholesterol: target all atherogenic lipoproteins.
2026
Notes that international guidelines consistently recommend specific LDL-C and lipid targets managed by statins and other therapies for diabetes patients according to risk.
Get citation
J, B., M, V., A, Z., N, M., D, M., & M, F. (2026). Lipid management in type 2 diabetes and non-HDL-cholesterol: target all atherogenic lipoproteins.. doi.org. https://doi.org/10.1186/s12933-026-03166-4

Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy.
2026
Indicates that major multisociety dyslipidemia guidelines explicitly incorporate diabetes status as an independent criterion for statin eligibility.
Get citation
TS, A., LM, W., & JB, S. (2026). Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy.. doi.org. https://doi.org/10.1001/jama.2026.11246

Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.
2026
Demonstrates that statin therapy significantly reduces cardiovascular events and mortality in older adults with type 2 diabetes within targeted risk brackets.
Get citation
L, C., W, X., EWY, C., & EYF, W. (2026). Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.. doi.org. https://doi.org/10.1371/journal.pmed.1005136

What does the evidence say?

The claim is specific, empirical, and contestable (or rather, verifiable through clinical guidelines and empirical literature). The retrieved literature uniformly points to the fact that major health organizations (such as the ADA, ACC, and AHA) issue clinical guidelines recommending statins for diabetic patients based on age and cardiovascular risk stratification, and that these therapies yield positive outcomes. Consequently, the balance verdict is SUPPORTED with zero refuting papers.

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 8304 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work